Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Eur J Clin Pharmacol. 2018 Sep 15;75(1):51–57. doi: 10.1007/s00228-018-2552-z

Table 1.

Patient Characteristics [n=13 subjects]

Demographics
Mean ± SD or N [%]
Age [years] 58 ± 10
Ethnicity
Caucasian 11 [85%]
Other 2 [15%]
Gender
Male 8 [61%]
Female 5 [39%]
Body Surface Area [m2] 1.9 ± 0.29
Cisplatin Dose [mg/m2] 53.5 ± 19
Baseline SCr [mg/dL] 0.91 ± 0.2
Change in SCr after first dose 0.02 ± 0.12
Baseline BUN [mg/dL] 15 ± 5
Change in BUN after first dose [mg/dL] −0.2 ± 4
Baseline eGFR [mL/min/1.73m2] 88 ±18
Change in eGFR after first dose
[mL/min/1.73m2]
−2 ± 16

Abbreviations: BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; SCr, serum creatinine; SD, standard deviation.